Lobbyist information

Amount

Jan Z. Rose	$248,100.00
Employed Terminated 01/01/2018

John Heffernan	$0.00
Employed Terminated 01/01/2018

Steven V. Miller	$91,999.99
Employed Terminated 01/01/2018

Terence P. McDermott	$239,999.98
Employed Terminated 01/01/2018

William P. McDermott	$557,999.99
Employed Terminated 01/01/2018

Total salaries paid:      $1,138,099.96

Client information

Amount

Alkermes	$60,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 All matters related to healthcare and pharmaceuticals.

Benchmark Senior Living LLC

$48,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Monitor legislative, regulatory or budgetary proposals related to SB345, An Act authorizing the option of providing basic common sense health services for residents of assisted living residences; legislation and regulatory matters pending before the legislature or executive branch including not limited to the Executive Office of Health and Human Services and Executive Office of Elder Affairs.

Bristol-Myers Squibb Company

$60,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all legislation and regulations pertaining to healthcare systems. Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research and development in the Commonwealth; and, any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's Medicaid or other publicly funded and reimbursed programs; any legislation or regulations related to payment reform, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing, and monitoring controlled substances and related policies, patient access drug pricing, drug transparency and prescribing related policies, drug safety. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health and Human Services, Division Of Insurance, Office of Attorney General, Center for Health Information and Analysis, MassHealth and Health Policy Commission.

CSX Transportation	$72,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 All legislation and regulations pertaining to Railroad Transportation.

Dana-Farber Cancer Institute

$60,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all legislation and regulations pertaining to hospitals, health care cost containment and reform, healthcare systems, health care access, wellness and prevention, cancer, palliative care, prescribing and dispensing, survivorship, implementation of Chapter 224 the Acts of 2012. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health and Human Services (EOHHS), Department of Public Health (DPH), Division of Insurance (DOI), MassHealth and related matters to Office of Attorney General (OAG), Center for Health Information and Analysis (CHIA) and Health Policy Commission (HPC).

DXC Technology Company	$96,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all matters related to DXC, healthcare and the delivery of innovative technology solutions in the Commonwealth.

Hebrew SeniorLife, Inc.

$72,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 All matters pertaining to health care, health care cost containment and reform, senior living policy and services; any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health & Human Services, Elder Affairs, Veterans Affairs, Economic Development & Housing, MassHealth, Attorney General's Office and Center for Health Information and Analysis and Health Policy Commission.

JPMorgan Chase Holdings LLC	$90,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 All legislation and regulations affecting the delivery of financial services in the Commonwealth. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to the Division Of Bank and the Office of the Attorney General.

Mallinckrodt LLC

$12,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 06/30/2018 Any and all legislation and regulations pertaining to healthcare systems. Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research and development in the Commonwealth; and, any legislation or regulations related to payment reform, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing, drug pricing, drug transparency and monitoring controlled substances and related policies, patient access, drug safety. Any and all legislature, regulation, policy matters pending before the legislation or executive branch including not limited to Executive Office of Health and Human Services, Department of Public Health, Division of Insurance, Center for Health Information and Analysis, Office of Massachusetts Attorney General and Health Policy Commission.

Massachusetts Biotechnology Council

$120,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all legislation and regulations pertaining to the healthcare system and health care cost containment and reform; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's; implementation of Chapter 224 the Acts of 2012, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies, greenbio policies, any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health and Human Services, Department of Public Health, Division of Insurance, MassHealth, Office of the Attorney General, Center for Health Information and Analysis and Health Policy Commission.

Merck Sharp & Dohme Corp.

$53,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Neutral: FY2015 Budget; S917 An Act Relative to Emergency Scheduling of Addictive Substances by the Commissioner of Public Health; H1 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent; H27 An Act Making Uniform the Law Regarding Trade Secrets; H825 An Act Regulating the Disposal of Prescription Medication; H1004 An Act Relative to Controlling Health Care Costs in the Commonwealth; H1019 An Act Making Greater Use of Managed Care in Medicaid; H1023 An Act to Protect Healthcare Reform Funding; S554 An Act to Protect Healthcare Reform Funding; H1676 An Act Criminalizing the Possession of Ingredients for Manufactured Drugs; H1927 An Act Relative to the Substitution of Interchangeable Biosimilars; H1953 An Act Promoting Research and Protecting Public Safety and Environment; H1962 An Act Relative to the Substitution of Generic Drugs; H1995 An Act Providing for Unused Medication Return by Health Care Facilities; H2082 An Act Establishing a Statewide Discount Program for Pharmaceuticals; S1094 An Act Establishing a Statewide Discount Program for Pharmaceuticals; H2108 An Act Relative to School Located Influenza Vaccination; S300 An Act Relative to the Prescription Drug Coverage for Seniors and the Disabled; S484 An Act Regulating Pharmacists as Health Care Providers; S499 An Act Concerning Medicaid and Accountable care; S544 An Act Improving Access to Coverage for Medicaid Beneficiaries; H1018 An Act Improving Access to Coverage for Medicaid Beneficiaries; Chapter 224 of Acts of 2012, An Act Improving The Quality Of Health Care and Reducing Costs Through Increased Transparency, Efficiency and Innovation; S1360 An Act Relative to Tax Credits for Prescription Drugs; H3734; H3667; H3457; H3711; Oppose: H729, S386 An Act Establishing the Commission on Extended Producer Responsibility, S386 An Act Establishing the Commission on Extended Producer Responsibility; H925 An Act Relative to Mandated Benefits; H1052 An Act Relative to Prescription Drugs; H1933 An Act Establishing Provisions for the Return of Expired Pharmaceuticals; H1940 An Act Relative to Safe Disposal of Medical Sharps; H1977 An Act Relative to Drug Disposal by Mail Prescriptions; H1988 An Act Relative to Suspending Prescription Drug Coverage from Minimum Creditable Coverage; H2018 An Act to Define Modest Meals and Refreshments in Prescriber Educational Settings; H2020 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education; S1050 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education; H2033 An Act Relative to Safe Disposal of Prescription Drugs; H2061 An Act Prohibiting Advertising by Pharmaceutical Companies; H2096 An Act Establishing a Special Commission to Study and Recommend Improvements in the Delivery of Prescription Drug Benefits for the Citizens of the Commonwealth; H2646 An Act to Eliminate the Tax Deduction for Direct to Consumer Pharmaceutical Marketing; S514 An Act Establishing a Public Health Insurance Option; S543 An Act to Ensure the Privacy of Patient Prescription Records; S569 An Act Relative to Mandatory Prescription Drug Coverage; S572 An Act to Ensure Effective Health Care Cost Control; S1051 An Act to Prevent Undue Influence on Prescriber Behavior; S1052 An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices; Support: H1268 An Act to Increase Access to Vaccines; H1956 An Act to Establish a Statewide Program to Promote Prevention, Diagnosis and Treatment of Type 2 Diabetes; H2012 An Act Establishing the Massachusetts Childhood Vaccine Program; S534 An Act Establishing the Massachusetts Childhood Vaccine Program; H2081 An Act Providing for the Establishment and Operation of a Cancer Drug Repository Program; H2112 An Act Relative to Provider Choice and Reliable Vaccine Management; S439 An Act Relative to Patient Medication Adherence; S477 An Act Relative to Patient Protection; S1021 An Act to Increase Access to Vaccines

Nellie Mae Education Foundation	$66,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 All legislation and regulations pertaining to directors of public charities

New England Baptist Hospital

$48,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 New England Baptist Hospital - Any and all legislation and regulations pertaining to hospitals, health care cost containment and reform, healthcare systems, health care access, wellness and prevention, implementation of Chapter 224 the Acts of 2012,. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health & Human Services, Department of Public Health, Division of Medicaid and related matters to Office of the Attorney General, Division of Insurance, the Center for Health Information and Analysis and the Health Policy Commission.

Sunovion Pharmaceuticals Inc.

$59,100.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all legislation and regulations pertaining to healthcare systems and health care cost containment and reform. Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research and development in the Commonwealth; and, any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's Medicaid or other publicly funded and reimbursed programs; any legislation or regulations related to payment reform, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing, and monitoring controlled substances and related policies, mental health, ADHD and epilepsy patient access and prescribing related policies, drug safety. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health and Human Services, Division of Insurance, MassHealth, Office of the Attorney General, Department of Mental Health, Center for Health Information and Analysis and Health Policy Commission.

Tufts Medical Center

$48,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all legislation and regulations pertaining to hospitals, healthcare systems, health care access, wellness and prevention, implementation of Chapter 224 the Acts of 2012. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health & Human Services, Division of Insurance, MassHealth and related matters to Office of the Attorney General, Center for Health Information Analysis and Health Policy Commission.

Wine & Spirits Wholesalers of MA	$174,999.96
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Wine & Spirits Wholesalers of MA Registration 2018 All legislation and regulations affecting the alcohol distribution, licensing and sale in MA.

Total salaries received:      $1,139,099.96

Expenditures

Amount